Product Watch
TRIVIMA™ PRO from HiMedia Laboratories Pvt. Ltd.
In the rapidly evolving field of biological research, a profound comprehension of cellular communication and biomolecular interactions is paramount for advancing human tissue development and drug discovery. In collaboration with the innovative Indian startup NBIL, HiMedia proudly unveils the TRIVIMA™ 3D bioprinter series, consisting of TRIVIMA™ Advanced, TRIVIMA™ Basic, and the star of the show, TRIVIMA™ Pro. These cutting-edge devices are poised to revolutionize research in tissue engineering, regenerative medicine, and drug development.
At the forefront of this innovative series is the TRIVIMA™ Pro, a groundbreaking bioprinter, tailored for advanced research. With the capacity for up to six modular print heads, it boasts an extensive temperature range, spanning from 8 °C to 250 °C. Moreover, it supports UV, blue, or visible light crosslinking, offering unparalleled flexibility for research in various fields, including tissue engineering, regenerative medicine, and drug development.
The TRIVIMA™ Advanced offers dual temperature-controlled print heads that provide temperature flexibility, from 8 °C to 60 °C for pneumatic heads and up to 250 °C for FDM extrusion. It also features a temperature-controlled print bed, ensuring precise temperature control ranging from 4 °C to 80 °C, creating an optimal bioprinting environment. Additionally, it supports various bioprinting modes for versatility.
The TRIVIMA™ Basic features up to two modular print heads with temperature control, accommodating a temperature range from room temperature to 60 °C for pneumatic heads.
TRIVIMA™, with its wide temperature range, modular print heads, and crosslinking capabilities, finds valuable application in a variety of fields:
Tissue engineering. TRIVIMA™ Pro is indispensable in the development of artificial tissues and organs. It allows for precise placement of bio-inks to create functional, viable tissue constructs, holding promise for regenerative medicine and transplants.
Drug development. Pharmaceutical research benefits from TRIVIMA™ Pro’s ability to produce 3D cellular models that mimic human tissues, enabling drug testing and screening with higher accuracy, reducing the need for animal testing.
Biomaterial research. In the field of materials science, the precise temperature control and versatile print heads of TRIVIMA™ Pro are harnessed to create and test new biomaterials for a range of applications, from implants to medical devices.
Cultivated meat. TRIVIMA™ Pro in cellular agriculture revolutionizes the food industry with sustainable, ethical bioprinted meat, eliminating traditional livestock farming.
Personalized medicine. TRIVIMA™ Pro enables the creation of patient-specific tissue models, allowing researchers to tailor treatment strategies, based on an individual’s unique genetic makeup, ultimately improving the efficacy of medical interventions.
These expanded applications underscore the wide-ranging impact of TRIVIMA™ Pro across various domains, from cutting-edge bioprinted meat production to the development of personalized medical treatments and microfluidic devices for innovative research and healthcare solutions.
Dr. Vishal G. Warke, M.B.B.S., Ph.D.
Director – Research and Development (Cell Biology),
HiMedia Laboratories Pvt. Ltd.
The expanding market of 3D bioprinting owes much of its growth to the increasing affordability of this cutting-edge technology. As the costs of 3D bioprinters gradually decrease, a broader spectrum of users, including smaller research laboratories, educational institutions, and startups, can now harness the potential of bioprinting. This accessibility has ushered in a new era of innovation, with more players entering the field. As a result, the 3D bioprinting market is expanding rapidly, with a growing number of applications across various sectors, from healthcare and biotechnology to education and consumer-driven industries, propelling the technology’s adoption and advancing its reach in the market.
